Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report

Anat R. Tambur; Oriol Bestard; Patricia Campbell; Anita S. Chong; Marta Crespo; Mandy L. Ford; Howard M. Gebel; Sebastiaan Heidt; Michelle Hickey; Annette Jackson; Vasilis Kosmoliaptsis; Carmen Lefaucheur; Kevin Louis; Roslyn B. Mannon; Michael Mengel; Anna Morris; David F. Pinelli; Elaine F. Reed; Carrie Schinstock; Jean Luc Taupin; Nicole Valenzuela; Chris Wiebe; Peter Nickerson

doi:10.1016/j.ajt.2022.11.009

Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report

Anat R. Tambur^*
, Oriol Bestard
, Patricia Campbell
, Anita S. Chong
, Marta Crespo
, Mandy L. Ford
, Howard M. Gebel
, Sebastiaan Heidt
, Michelle Hickey
, Annette Jackson
, Vasilis Kosmoliaptsis
, Carmen Lefaucheur
, Kevin Louis
, Roslyn B. Mannon
, Michael Mengel
, Anna Morris
, David F. Pinelli
, Elaine F. Reed
, Carrie Schinstock
, Jean Luc Taupin

Nicole Valenzuela, Chris Wiebe, Peter Nickerson

^*Corresponding author for this work

Northwestern University
Vall d'Hebron Institute of Oncology
University of Alberta
The University of Chicago
Hospital del Mar
Emory University
Emory University School of Medicine
Leiden University Medical Centre
David Geffen School of Medicine
Duke University School of Medicine
University of Cambridge
Université Paris Cité
University of Nebraska Medical Center
Mayo Clinic Rochester, MN
Hospital St. Louis
University of Manitoba

Research output: Contribution to journal › Article › Academic › peer-review

65 Citations (Scopus)

49 Downloads (Pure)

Abstract

The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.

Original language	English
Pages (from-to)	133-149
Number of pages	17
Journal	American Journal of Transplantation
Volume	23
Issue number	1
DOIs	https://doi.org/10.1016/j.ajt.2022.11.009
Publication status	Published - Jan 2023
Externally published	Yes

Bibliographical note

Access to Document

10.1016/j.ajt.2022.11.009Licence: CC BY-NC-ND

1-s2.0-S1600613522247868-mainFinal published version, 2.42 MBLicence: CC BY-NC-ND

Cite this

Tambur, A. R., Bestard, O., Campbell, P., Chong, A. S., Crespo, M., Ford, M. L., Gebel, H. M., Heidt, S., Hickey, M., Jackson, A., Kosmoliaptsis, V., Lefaucheur, C., Louis, K., Mannon, R. B., Mengel, M., Morris, A., Pinelli, D. F., Reed, E. F., Schinstock, C., ... Nickerson, P. (2023). Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report. American Journal of Transplantation, 23(1), 133-149. https://doi.org/10.1016/j.ajt.2022.11.009

@article{d4e359030bf049b4aa86d76d972e99fa,

title = "Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report",

abstract = "The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.",

author = "Tambur, \{Anat R.\} and Oriol Bestard and Patricia Campbell and Chong, \{Anita S.\} and Marta Crespo and Ford, \{Mandy L.\} and Gebel, \{Howard M.\} and Sebastiaan Heidt and Michelle Hickey and Annette Jackson and Vasilis Kosmoliaptsis and Carmen Lefaucheur and Kevin Louis and Mannon, \{Roslyn B.\} and Michael Mengel and Anna Morris and Pinelli, \{David F.\} and Reed, \{Elaine F.\} and Carrie Schinstock and Taupin, \{Jean Luc\} and Nicole Valenzuela and Chris Wiebe and Peter Nickerson",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",

year = "2023",

month = jan,

doi = "10.1016/j.ajt.2022.11.009",

language = "English",

volume = "23",

pages = "133--149",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Elsevier",

number = "1",

}

Tambur, AR, Bestard, O, Campbell, P, Chong, AS, Crespo, M, Ford, ML, Gebel, HM, Heidt, S, Hickey, M, Jackson, A, Kosmoliaptsis, V, Lefaucheur, C, Louis, K, Mannon, RB, Mengel, M, Morris, A, Pinelli, DF, Reed, EF, Schinstock, C, Taupin, JL, Valenzuela, N, Wiebe, C & Nickerson, P 2023, 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report', American Journal of Transplantation, vol. 23, no. 1, pp. 133-149. https://doi.org/10.1016/j.ajt.2022.11.009

TY - JOUR

T1 - Sensitization in transplantation

T2 - Assessment of Risk 2022 Working Group Meeting Report

AU - Tambur, Anat R.

AU - Bestard, Oriol

AU - Campbell, Patricia

AU - Chong, Anita S.

AU - Crespo, Marta

AU - Ford, Mandy L.

AU - Gebel, Howard M.

AU - Heidt, Sebastiaan

AU - Hickey, Michelle

AU - Jackson, Annette

AU - Kosmoliaptsis, Vasilis

AU - Lefaucheur, Carmen

AU - Louis, Kevin

AU - Mannon, Roslyn B.

AU - Mengel, Michael

AU - Morris, Anna

AU - Pinelli, David F.

AU - Reed, Elaine F.

AU - Schinstock, Carrie

AU - Taupin, Jean Luc

AU - Valenzuela, Nicole

AU - Wiebe, Chris

AU - Nickerson, Peter

PY - 2023/1

Y1 - 2023/1

N2 - The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.

AB - The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.

UR - https://www.scopus.com/pages/publications/85146856447

U2 - 10.1016/j.ajt.2022.11.009

DO - 10.1016/j.ajt.2022.11.009

M3 - Article

C2 - 36695615

AN - SCOPUS:85146856447

SN - 1600-6135

VL - 23

SP - 133

EP - 149

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 1

ER -

Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this